*0011067482
*00520190130100003.0
*007ta
*008030825s2002 xx# 000 u eng d
*00901605caa a2200349 c 4500
*019 $bk
*035 $a(EXLNZ-47BIBSYS_NETWORK)990314122034702201
*035 $a(NO-TrBIB)031412203
*035 $a031412203-47bibsys_network
*040 $aNO-TrBIB$bnob$ekatreg
*24502$aA randomised comparison of bicalutamide ('casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate cancer$cP. Iversen...[et al.]
*260 $c2002
*300 $as.204-211
*500 $aØvrige forfattere: T.L.J. Tammela, S.Vaage, O. Lukkarinen, P. Lodding, T. Bull-Njaa, J. Viitanen, P. Hoisaeter, P. Lundmo, F. Rasmussen, J.E. Johansson, B.E. Persson, K. Carroll
*653 $aAker$auniversitetssykehus$aOslo$aurologiske$auniversitetsklinikk$_123825100
*7001 $aBull-Njaa, T.$0(NO-TrBIB)1029307$_127474100
*7001 $aCarroll, K.$0(NO-TrBIB)3080906$_127474200
*7001 $aHøisæter, Per Åge,$d1938-$0(NO-TrBIB)97018949$_29453600
*7001 $aIversen, P.$0(NO-TrBIB)3080923$_127474300
*7001 $aJohansson, J.E.$0(NO-TrBIB)3080910$_127474400
*7001 $aLodding, P.$0(NO-TrBIB)3080917$_127474500
*7001 $aLukkarinen, O.$0(NO-TrBIB)3080918$_127474600
*7001 $aLundmo, Per I.$0(NO-TrBIB)90288724$_20650800
*7001 $aPersson, B.E.$0(NO-TrBIB)3080908$_127474700
*7001 $aRasmussen, F.$0(NO-TrBIB)3080911$_127474800
*7001 $aTammela, T.L.J.$0(NO-TrBIB)3080920$_127474900
*7001 $aVaage, S.$0(NO-TrBIB)3080919$_127475000
*7001 $aViitanen, J.$0(NO-TrBIB)3080915$_127475100
*7730 $tEuropean urology (trykt utg.).$dOxford : Elsevier Science$g42(2002)3$x0302-2838$w999303734484702201$w(NO-LaBS)174537(tnr)
*901 $a80
*999 $aoai:nb.bibsys.no:990314122034702202$b2021-11-02T03:13:41Z$z990314122034702202
^